| ||||||||||||||
|
|
|||||||||||||
University of Washington, Seattle, Washington.
Abstract
We have determined that the mixed agonist-antagonist narcotic, butorphanol, improves CO, response and ventilation after fentanyl anesthesia. A tentative dosage range has been established. Twenty-two patients were anesthetized with isoflurane, nitrous oxide, and fentanyl, which was continuously infused throughout the study. Postoperatively three 1-mg doses of butorphanol were administered IV. Blood pressure, heart rate, plasma epinephrine and norepinephrine concentrations, and pain intensity were essentially unchanged after butorphanol. Most of the improvement in breathing occurred after the first 1-mg dose. Mean respiratory rate increased from 7.8 ± 5.0 to 11.0 ± 4.8 min (P
0.005), tidal volume increased from 469 ± 302 to 844 ± 390 ml (P
0.005), minute ventilation increased from 4.32 ± 2.97 to 8.51 ± 3.14 L/min (P
0.005), and the slope of the ventilatory response to CO2 increased from 0.36 ± 0.37 to 0.90 ± 0.80 L·min 1·mm Hg 1(P
0.05). Resting PaCO2 decreased from a baseline of 57.8
11.1 to 51.7 ± 5.12 mm Hg (P
0.05) after the third dose.
Key Words: ANALGESICS—fentanyl, butorphanol ANTAGONISTS, narcotic—butorphanol VENTILATION—CO2 response curves
This article has been cited by other articles:
![]() |
H. R. Garner, T. F. Burke, C. D. Lawhorn, J. M. Stoner, and W. D. Wessinger Butorphanol-Mediated Antinociception in Mice: Partial Agonist Effects and Mu Receptor Involvement, J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1253 - 1261. [Abstract] [Full Text] |
||||
|